China Pharma Holdings, Inc.CPHINYSE
Loading
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 3.68% |
| Q2 2025 | 14.04% |
| Q1 2025 | 36.57% |
| Q4 2024 | -10.21% |
| Q3 2024 | 22.01% |
| Q2 2024 | -51.90% |
| Q1 2024 | 22.66% |
| Q4 2023 | -66.00% |
| Q3 2023 | -56.37% |
| Q2 2023 | -14.80% |
| Q1 2023 | 66.00% |
| Q4 2022 | -69.75% |
| Q3 2022 | 11.66% |
| Q2 2022 | 14.49% |
| Q1 2022 | -40.55% |
| Q4 2021 | 14.92% |
| Q3 2021 | -1.26% |
| Q2 2021 | -8.11% |
| Q1 2021 | 36.77% |
| Q4 2020 | -15.64% |
| Q3 2020 | -1370.25% |
| Q2 2020 | 112.51% |
| Q1 2020 | 63.91% |
| Q4 2019 | -157.34% |
| Q3 2019 | 14.31% |
| Q2 2019 | -125.30% |
| Q1 2019 | 67.61% |
| Q4 2018 | 46.58% |
| Q3 2018 | -123.44% |
| Q2 2018 | -514.42% |
| Q1 2018 | 91.57% |
| Q4 2017 | -91.53% |
| Q3 2017 | 24.47% |
| Q2 2017 | -43.71% |
| Q1 2017 | -40.87% |
| Q4 2016 | 36.91% |
| Q3 2016 | 35.45% |
| Q2 2016 | -5.88% |
| Q1 2016 | 77.67% |
| Q4 2015 | -285.29% |